|
|
Volumn 38, Issue 5, 1999, Pages 663-665
|
|
Breakthrough Candida tropicalis fungemia during ketoconazole prophylaxis in cancer patients [1]
a a a |
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMINOGLYCOSIDE ANTIBIOTIC AGENT;
AMPHOTERICIN B;
CEPHALOSPORIN DERIVATIVE;
CORTICOSTEROID;
FLUCONAZOLE;
IMIPENEM;
ITRACONAZOLE;
KETOCONAZOLE;
OFLOXACIN;
QUINOLONE DERIVATIVE;
VANCOMYCIN;
ADOLESCENT;
ADULT;
ANTIBIOTIC PROPHYLAXIS;
BLOOD CULTURE;
CANCER;
CANCER CHEMOTHERAPY;
CANCER PATIENT;
CANDIDA ALBICANS;
CANDIDA GLABRATA;
CANDIDA KRUSEI;
CANDIDA TROPICALIS;
CENTRAL VENOUS CATHETERIZATION;
CHILD;
FEMALE;
FUNGEMIA;
HUMAN;
LETTER;
MAJOR CLINICAL STUDY;
MALE;
MORBIDITY;
NEUTROPENIA;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
RISK FACTOR;
TRICHOSPORON;
ADULT;
ANTIBIOTIC PROPHYLAXIS;
ANTIFUNGAL AGENTS;
CANDIDA;
CANDIDIASIS;
CHILD;
FEMALE;
FUNGEMIA;
HUMANS;
INCIDENCE;
KETOCONAZOLE;
MALE;
NEOPLASMS;
|
|
EID: 0032865627
PISSN: 0284186X
EISSN: None
Source Type: Journal
DOI: 10.1080/028418699431294 Document Type: Letter |
|
Times cited : (3)
|
|
References (9)
|